Comparing CHF Solutions (CHFS) and Magna-Lab (MAGAA)

CHF Solutions (NASDAQ:CHFS) and Magna-Lab (OTCMKTS:MAGAA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, earnings, dividends and profitability.

Volatility & Risk

CHF Solutions has a beta of 2.33, indicating that its stock price is 133% more volatile than the S&P 500. Comparatively, Magna-Lab has a beta of 17.11, indicating that its stock price is 1,611% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations and price targets for CHF Solutions and Magna-Lab, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CHF Solutions 0 0 1 0 3.00
Magna-Lab 0 0 0 0 N/A

CHF Solutions presently has a consensus target price of $3.30, suggesting a potential upside of 230.00%. Given CHF Solutions’ higher probable upside, equities analysts plainly believe CHF Solutions is more favorable than Magna-Lab.

Valuation & Earnings

This table compares CHF Solutions and Magna-Lab’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CHF Solutions $3.55 million 1.99 -$13.38 million ($37.15) -0.03
Magna-Lab N/A N/A -$140,000.00 N/A N/A

Magna-Lab has lower revenue, but higher earnings than CHF Solutions.

Insider & Institutional Ownership

20.0% of CHF Solutions shares are owned by institutional investors. 3.5% of CHF Solutions shares are owned by company insiders. Comparatively, 15.3% of Magna-Lab shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares CHF Solutions and Magna-Lab’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CHF Solutions -471.94% -166.88% -139.42%
Magna-Lab N/A N/A -2,800.00%

CHF Solutions Company Profile

CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It offers Aquadex FlexFlow consoles and the related disposable products in Singapore and Hong Kong. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.

Magna-Lab Company Profile

Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. Magna-Lab Inc. was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.

Receive News & Ratings for CHF Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CHF Solutions and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply